You are here

Article Text

Article menu
Download PDFPDF
Review Article
Introduction
  1. Andrés Poveda, MD
  1. Area Clínica de Oncologia, Ginecológica Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  1. Address correspondence and reprint requests to Andrés Poveda, MD, Fundación Instituto Valenciano de Oncología, Valencia, Spain. E-mail: apoveda{at}fivo.org

Abstract

Ovarian cancer is the second most common gynecological cancer, representing 5% of all cancers in women. It has the highest case-fatality rate of all gynecological malignancies. In the European Union, there are approximately 48,000 new cases of ovarian cancer and 31,000 deaths per year. Similarly, in the United States, there are approximately 25,500 new cases per year, with 16,000 deaths associated.

  • Trabectedin
  • Relapsed ovarian cancer
  • Platinum sensitive

https://doi.org/10.1097/IGC.0b013e318217b337

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Disclosure: Editorial assistance for the preparation of this manuscript was funded by PharmarMar.